OTCMKTS:NVZMF

Novozymes A/S - NVZMF Stock Forecast, Price & News

$50.72

-0.64 (-1.25%)

(As of 03/28/2023 12:00 AM ET)

Add

Compare

Today's Range: $48.96
▼
$51.15
50-Day Range: $47.22
▼
$53.00
52-Week Range: $38.16
▼
$70.50

Volume: 2,817 shs
Average Volume: 3,358 shs
Market Capitalization: N/A

P/E Ratio: 6.32
Dividend Yield: 3.55%
Price Target: N/A

About Novozymes A/S (OTCMKTS:NVZMF) Stock

Novozymes A/S engages in the research and development of biotechnology solutions, which produces industrial enzymes and microorganisms. Its business areas include agriculture, bioenergy, biopharma, food and beverage, household care, leather, pulp and paper, textile and wastewater solutions. The company was founded in 2000 and is headquartered in Copenhagen, Denmark.

Receive NVZMF Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Novozymes A/S and its competitors with MarketBeat's FREE daily newsletter.

NVZMF Stock News Headlines

March 8, 2023 | finance.yahoo.com

Invitation to an extraordinary shareholders’ meeting of Novozymes A/S

February 24, 2023 | finance.yahoo.com

WLKP vs. NVZMY: Which Stock Should Value Investors Buy Now?

March 29, 2023 | Investing Daily (Ad)

A 100% Win Rate In 2022…

The next 10 minutes could change your life. We've recorded a special sit-down interview with a reclusive millionaire who details how he's closed out winning trade after winning trade throughout the volatility of 2022. In fact, he hasn't closed a single losing trade since 2016. Sounds impossible? It's not - and he'll prove it to you.

February 3, 2023 | finance.yahoo.com

Invitation to Novozymes' annual shareholders' meeting 2023

January 25, 2023 | edition.cnn.com

EU red tape creates ‘roadblocks’ on sustainability, says Novozymes boss

January 12, 2023 | finance.yahoo.com

Novozymes A/S (NVZMF)

December 12, 2022 | msn.com

Novozymes is set to merge with Chr. Hansen as part of a historic deal

November 5, 2022 | seekingalpha.com

Novozymes A/S (NVZMF) Q3 2022 Earnings Call Transcript

March 29, 2023 | Behind the Markets (Ad)

Buy THIS stock before Taiwan is attacked

... If the United States goes to war with another nuclear armed superpower, this could have a devastating impact on your retirement portfolio. Now, even Taiwan's own foreign minister is saying that China is on the cusp of a full scale invasion. But the good news is, if China invades Taiwan, there is a way to protect yourself.

November 3, 2022 | finance.yahoo.com

Novozymes confirms upgraded guidance by strong start to Q4

November 1, 2022 | finance.yahoo.com

Novozymes Named EPA Safer Choice Partner of the Year for Second Consecutive Year

August 14, 2022 | seekingalpha.com

Novozymes A/S 2022 Q1 - Results - Earnings Call Presentation

August 11, 2022 | finance.yahoo.com

Novozymes delivers strong half year results and narrows full-year outlook upwards

July 15, 2022 | finance.yahoo.com

Novozymes plan to further increase prices across the portfolio in response to the significant and persistent hike in incoming cost

June 7, 2022 | finance.yahoo.com

Novozymes extends the lifetime of textiles with sustainable innovation

April 27, 2022 | seekingalpha.com

Novozymes A/S (NVZMF) CEO Ester Baiget on Q1 2022 Results - Earnings Call Transcript

April 26, 2022 | finance.yahoo.com

Novozymes delivers strong 2022 Q1 results and raises full-year financial guidance

January 18, 2022 | nasdaq.com

Novozymes AS - Class B (NVZMF)

December 16, 2021 | finance.yahoo.com

Closing the gap between sustainability and profits in corn wet milling

December 16, 2021 | finance.yahoo.com

Marrone Bio Optimizes Bioherbicide with New Bacteria Strains, Accelerates Product Development to Enter $27 Billion Herbicide Market¹

December 13, 2021 | finance.yahoo.com

Novozymes and Saipem enter collaboration agreement to create a more sustainable CO2 capture

September 26, 2021 | markets.businessinsider.com

Novozymes A/S : Novozymes is combining cutting-edge science and business expertise to help feed the world sustainably

August 31, 2021 | finanznachrichten.de

Novozymes Bioenergy Business Threatened by Electric Cars, Bank of America Says

August 12, 2021 | finance.yahoo.com

Novozymes reaches a strategic milestone in the implementation of its strategy with a significant entry into Advanced Protein Solutions

August 12, 2021 | finance.yahoo.com

Interim report for 1H 2021

August 12, 2021 | finance.yahoo.com

Novozymes delivers strong Q2 results and narrows full-year guidance to the high-end of the range

May 17, 2021 | finance.yahoo.com

AXTA vs. NVZMY: Which Stock Should Value Investors Buy Now?

See More Headlines

30 days | 90 days | 365 days | Advanced Chart

Receive NVZMF Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Novozymes A/S and its competitors with MarketBeat's FREE daily newsletter.

NVZMF Company Calendar

Last Earnings: 4/20/2016
Today: 3/28/2023

Get Stock Alerts

Industry, Sector and Symbol

Stock Exchange: OTCMKTS
Industry: Biotechnology
Sub-Industry: N/A
Sector: Medical
Current Symbol: OTCMKTS:NVZMF
CUSIP: N/A
CIK: 1131345
Web: www.novozymes.com
Phone: (454) 446-0000
Fax: N/A
Employees: 6,184
Year Founded: N/A

Profitability

EPS (Most Recent Fiscal Year): N/A
Trailing P/E Ratio: 6.32
Forward P/E Ratio: N/A
P/E Growth: N/A
Net Income: N/A
Net Margins: N/A
Pretax Margin: N/A
Return on Equity: N/A
Return on Assets: N/A

Debt

Debt-to-Equity Ratio: N/A
Current Ratio: N/A
Quick Ratio: N/A

Sales & Book Value

Annual Sales: N/A
Price / Sales: N/A
Cash Flow: N/A
Price / Cash Flow: N/A
Book Value: N/A
Price / Book: N/A

Miscellaneous

Outstanding Shares: N/A
Free Float: N/A
Market Cap: N/A
Optionable: Not Optionable
Beta: N/A

Key Executives

Ester Baiget
President & Chief Executive Officer

Graziela Chaluppe dos Santos Malucelli
Chief Operating Officer & Executive VP

Lars Green
Chief Financial Officer & Executive Vice President

Claus Crone Fuglsang
Executive Vice President-Research & Development

Anders Lund
EVP & Head-Consumer Biosolutions

Key Competitors

View All Competitors

NVZMF Stock - Frequently Asked Questions

How have NVZMF shares performed in 2023?: Novozymes A/S's stock was trading at $50.36 on January 1st, 2023. Since then, NVZMF shares have increased by 0.7% and is now trading at $50.72.
View the best growth stocks for 2023 here.
How were Novozymes A/S's earnings last quarter?: Novozymes A/S (OTCMKTS:NVZMF) announced its quarterly earnings data on Wednesday, April, 20th. The biotechnology company reported $0.37 earnings per share for the quarter, missing analysts' consensus estimates of $2.43 by $2.06.
Is Novozymes A/S a good dividend stock?: Novozymes A/S (OTCMKTS:NVZMF) pays an annual dividend of $1.80 per share and currently has a dividend yield of 0.72%. The dividend payout ratio is 22.44%. This payout ratio is at a healthy, sustainable level, below 75%.
What is Novozymes A/S's stock symbol?: Novozymes A/S trades on the OTCMKTS under the ticker symbol "NVZMF."

How do I buy shares of Novozymes A/S?: Shares of NVZMF stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.
What is Novozymes A/S's stock price today?: One share of NVZMF stock can currently be purchased for approximately $50.72.
How many employees does Novozymes A/S have?: The company employs 6,184 workers across the globe.
How can I contact Novozymes A/S?: Novozymes A/S's mailing address is Krogshoejvej 36, BAGSVAERD, 2880, Denmark. The official website for the company is www.novozymes.com. The biotechnology company can be reached via phone at (454) 446-0000.

This page (OTCMKTS:NVZMF) was last updated on 3/29/2023 by MarketBeat.com Staff

Get 30 Days of MarketBeat All Access Free

Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations
Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.
Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your 30-Day Free Trial

Novozymes A/S - NVZMF Stock Forecast, Price & News

About Novozymes A/S (OTCMKTS:NVZMF) Stock

NVZMF Stock News Headlines

NVZMF Company Calendar

Industry, Sector and Symbol

Profitability

Debt

Sales & Book Value

Miscellaneous

Key Executives

Key Competitors

NVZMF Stock - Frequently Asked Questions

About MarketBeat

Popular Tools

Financial Calendars

Terms & Info